Visit the website of BridgeBio Pharma (NDQ:BBIO), and you'll find it describes itself as 'a unique biotechnology company advancing genetic medicines via a ...
Ascendis Pharma (NDQ:ASND) has a portfolio of drugs that could be the most important to hit the market since BioMarin's Voxzogo (vosoritide). This became one ...
NEXTDC (ASX:NXT) has cut FY27 revenue and EBITDA guidance by around A$140m after Jemena suspended power works at its M3 ...
LinQ Minerals (ASX:LNQ) reports 429m of visual mineralisation at Gidginbung South, with assays due in 6 to 8 weeks to confirm ...
North America CEO Kristie Keast is leaving at the end of October 2026, with Sue Stark stepping in as interim leader.
Sigma Healthcare (ASX:SIG) posted 12.1% Chemist Warehouse sales growth and 9.8% like-for-like after cycling the GLP-1 boost ...
SpaceX (NSDQ:SPCX) delivered US$14.6bn Q3 revenue as Super Intelligence turned profitable, but investors still face a ...
Roivant Sciences (NASDAQ:ROIV) has spent the past decade attempting something uncommon in the biotech space. Namely, creating a system for repeatedly building ...
Apple (AAPL) stock falls after Loop Capital cuts its target to US$330 and warns 13 million planned iPhone shipments may not recover. What investors should know.
Can be BeOne Medicines (NDQ:ONC) become a global oncology superpower? For many aspirants, the biggest impediment is the lack ...
SpaceX (SPCX) beats Q3 estimates as AI revenue surges 830% to US$7.56 billion. Discover what drove the earnings jump and why ...
SpaceX (SPCX) could need US$230 billion in AI-related borrowing by 2029, Morgan Stanley warns. Here's what the financing risk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results